Bioinformatics investigation of the effect of lycopene on the expression of heat shock proteins (hsp27) in prostate cancer

Document Type : Brief Communication

Author

Members of Academic Board

Abstract
In most cancers, the expression level of heat shock proteins is increased, which makes cancer cells resistant to drug therapy and has a poor prognosis. They have also been linked to cell proliferation, invasion and metastasis. Lycopene, as a carotenoid, is an effective antioxidant used to prevent the growth of cancerous glands. Prostate cancer is one of the most common cancers seen in men. To treat this disease, surgery and chemotherapy are mostly used, which have many complications after treatment and are costly. In this study, prostate cancer was treated with lycopene and raw microarray big data were received from GEO section of NCBI database. Then, the expression changes of heat shock proteins (hsp27) were determined using bioinformatics tools and methods, and comparing the expression levels of lycopene-treated genes with non-treated ones showed that the expression level of HSPB8 gene was drastically reduced and also, no significant changes were observed in the expression level of other gene families in this group. Results show that lycopene can cause stress in cancer cells and this stress predisposes the cell to apoptosis.

Keywords

Subjects


1-Zügel U, Kaufmann SHE. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clinical Microbiology Reviews. 1999.
2-A. Panahi, R. Nakhaei Sistanib. Sadeghizadeha Dendrosomal Nanocurcumin Induces Changes in the Expression Levels of Heat Shock Proteins in the AGS Cell Line: Cellular Tolerance or Smart Apoptosis December. 2016.
3-Telser A. Molecular Biology of the Cell, 4th Edition. Shock. 2002.
4-Ciocca DR, Calderwood SK. Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress and Chaperones. 2005.
5-Beere HM. “The stress of dying”: The role of heat shock proteins in the regulation of apoptosis. Journal of Cell Science. 2004.
6-Tang D, Khaleque MA, Jones EL, Theriault JR, Li C, Wong WH, et al. Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones. 2005.
7-Turi Z, Hocsak E, Racz B, Szabo A, Balogh A, Sumegi B, et al. Role of mitochondrial network stabilisation by a human small heat shock protein in tumour malignancy. J Cancer. 2015.
8-Oshita SE, Chen F, Kwan T, Yehiely F, Cryns VL. The small heat shock protein HspB2 is a novel anti-apoptotic protein that inhibits apical caspase activation in the extrinsic apoptotic pathway. Breast Cancer Res Treat. 2010.
9- Rao AV, and Ali A. Biologically active phytochemicals in humanhealth:
lycopene. 2007.
10-Roberts MJ, Teloken P, Chambers SK, Williams SG, Yaxley J, Samaratunga H, et al. Prostate Cancer Detection. Endotext. 2000.
11-Aslam HM, Shahid N, Shaikh NA, Shaikh HA, Saleem S, Mughal A. Spectrum of prostatic lesions. Int Arch Med. 2013.
12-Holzapfel NP, Holzapfel BM, Champ S, Feldthusen J, Clements J, Hutmacher DW. The potential role of lycopene for the prevention and therapy of prostate cancer: From molecular mechanisms to clinical evidence. International Journal of Molecular Sciences. 2013.
13-Tang D, Khaleque MA, Jones EL, Theriault JR, Li C, Wong WH, et al. Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones. 2005.
14-Blagosklonny. M.V, Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Can-cer Inst 93.2001.
15-Scieglinska D, Gogler-Piglowska A, Butkiewicz D, Chekan M, Malusecka E, Harasim J, et al. HSPA2 is expressed in human tumors and correlates with clinical features in non-small cell lung carcinoma patients. Anticancer Res. 2014.
16-Piccolella M, Crippa V, Cristofani R, Rusmini P, Galbiati M, Cicardi ME, et al. The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells. Oncotarget. 2017.